MicroRNAs in Patients With Neurofibromatosis Type 1

Launched by ANN & ROBERT H LURIE CHILDREN'S HOSPITAL OF CHICAGO · May 8, 2012

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients ages 2 years to 21 years.
• • Patients with NF-1 being followed in the Neurofibromatosis Clinic.
• • Patients have had MRI imaging in the 24 months prior to enrollment on the study.
• • Patients may have known concurrent malignancies such as plexiform neurofibroma.
• • Patients and/or parents/legal guardians must have signed an informed consent and assent when applicable.
• Exclusion Criteria:
• • Patients who have had prior tumor-directed therapy (including chemotherapy and/or radiation)
• • Patients with a prior or current diagnosis of a malignant peripheral nerve sheath tumor.
• • Patients who are considered too ill to participate as determined by their treating physician
• • Patients who are pregnant or lactating